J Korean Med Assoc Search

CLOSE


J Korean Med Assoc > Volume 48(5); 2005 > Article
Ahn: Do Natural Health Products Cause Toxic Hepatitis ?

Abstract

Medicinal herb-induced liver injury reported on the literature ranges from mild elevation of liver enzymes to fulminant liver failure and liver cirrhosis. Medicinal herbs are common ingredients of traditional Chinese herbs. The mechanisms of medicinal herb-induced liver injury are mainly intrinsic hepatotoxicity. In addition to the potential for hepatotoxicity, medicinal herbs frequently induce herb-drug interaction and herb-herb interaction and may affect its own efficacy and safety. Sometimes hepatotoxicity of medicinal herbs originates from the substances of illegal adulterations and contaminations rather than its own indigenous components. Moreover, individual susceptibility to toxic liver injury should be considered in every instance. Two big problems exist in the management of medicinal herbs-induced liver injury. Because the release of prescriptions is not obligatory in Korea, it is impossible to identify ingredients in case of medicinal herbs-induced liver injury. Misconception on the safety of medicinal herbs prevails throughout the country.

References

1. Kessler RC, Davis RB, Foster DF, Van Rompay MI, Walters EE, Eisenberg DM, et al. Long-term trends in the use of complementary and alternative medical therapies in the United States. Ann Intern Med 2001;135:262-268.

2. Kraft K, Loew D, Schneider B, Kemper FH. Planning, realization and evaluation of post-marketing surveillance studies. Recommendations of the Society for Phytotherapy. Arzneimittelforschung 1997;47:990-994.

3. Castot A, Djezzar S, Deleau N, Guillot B, Efthymiou ML. Pharmacovigilance off the beaten track: herbal surveillance or pharmacovigilance of medicinal plants. Therapie 1997;52:97-103.

4. Barnes J. Pharmacovigilance of herbal medicines: a UK perspective. Drug Saf 2003;26:829-851.

5. Lavy T, Haran B, Shemer J, Shani S. Regulation of natural medicines in Israel and abroad. Harefuah 2000;139:339-344.

6. Briggs DR. The regulation of herbal medicines in Australian. Toxicology 2002;181-2:565-570.

7. Rousseaus CG, Schachter H. Regulation issues concerning the safety, efficacy and quality of herbal remedies. Birth Defects Res B Dev Reprod Toxicol 2003;68:505-510.

8. Hartigan-Go K. Developing a pharmacovigilance system in the philippines, a country of diverse culture and strong traditional medicine background. Toxicology 2002;181-2:103-107.

10. Benninger J, Schneider HT, Schuppan D, Kirchner T, Hahn EG. Acute hepatitis induced by greater celandine(Chelidonium majus). Gastroenterology 1999;117:1234-1237.

11. De Berardinis V, Moulis C, Maurice M, Beaune P, Pessayre D, Loeper J, et al. Human microsomal epoxide hydrolase is the target of germander-induced autoantibodies on the surface of human hepatocytes. Mol Pharmacol 2000;58:542-551.

12. Ben Yahia M, Mavier P, Metreau JM, Zafrani ES, Fabre M, Mallat A, et al. Chronic active hepatitis and cirrhosis induced by wild germander. 3 cases. Gastroenterol Clin Biol 1993;17:959-962.

13. Ahn BM. Herbal preparation-induced liver injury. Korean J Gastroenterol 2004;44:113-125.

14. Ahn BM, Lee YJ, Lee KM, Lee DS, Yang JM, Park DH, et al. Prevalence of herbal preparation-induced acute liver injury in hospitalized adults in Korea. Korean J Hepatol 2001;7:67.

15. Kim DJ, Ahn BM, Choi SK, Suh JI, Park SH, Oh SM, et al. Preliminary multi-center studies on toxic liver injury. Korean J Hepatol 2004;10:80-86.

16. Castot A, Larrey D. Hepatitis observed during a treatment with a drug or tea containing Wild Germander. Evaluation of 26 cases reported to the Regional Centers of Pharmcovigilance. Gastroenterol Clin Biol 1992;16:916-922.

17. Favreau JT, Ryu ML, Braunstein G, Orshansky G, Park SS, Fong TL, et al. Severe hepatotoxicity associated with the dietary supplement LipoKinetix. Ann Intern Med 2002;136:590-595.

18. Nadir A, Agrawal S, King PD, Marshall JB. Acute hepatitis associated with the use of a Chinese product, Ma-huang. Am J Gastroenterol 1996;91:1436-1438.

19. Stickel F, Baumuller HM, Seitz K, Vasilakis D, Seitz G, Schuppan D, et al. Hepatitis induced by kava(Piper methyscum rhizoma). J Hepatol 2003;39:62-67.

20. Sheikh NM, Philen RM, Love LA. Chaparral-associated hepatotoxicity. Arch Intern Med 1997;157:913-919.

21. Perron AD, Patterson JA, Yanofsky NN. Kombucha "mushroom" hepatotoxicity. Ann Emerg Med 1995;26:660-661.

22. Lee DS, Baek JT, Kim JS, Jeung SJ, Lee HK, Yang KH, et al. A case of toxic hepatitis caused by the Chinese diet food. Korean J Med 2003;65:689-692.

23. Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Kessler RC, et al. Trends in alternative medicine use in the United States, 1990~1997: results of a follow-up national survey. JAMA 2000;280:1569-1575.

24. Watkins RE, Maglich JM, Moore LB, Wisely GB, Noble SM, Redinbo MR, et al. 2.1 A crystal structure of human PXR in complex with the St. John's wort compound hyperforin. Biochemistry 2003;18:1430-1438.

25. Zhou S, Lim LY, Chowbay B. Herbal modulation of P-glycoprotein. Drug Metab Rev 2004;36:57-104.

26. Lehmann JM, McKee DD, Watson MA, Willson TM, Moore JT, Kliewer SA. The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. J Clin Invest 1998;102:1016-1023.

27. Barone GW, Gurley BJ, Ketel BL, Abul-Ezz SR. Herbal supplements: a potential for drug interactions in transplants. Transplantation 2001;71:239-241.

28. Miller LG. Herbal medicinals. Selected clinical considerations focusing on known or potential drug-herb interactions. Arch Intern Med 1998;158:2200-2211.

29. Khojasteh-Bakht SC, Chen W, Konigs LL, Peter RM, Nelson SD. Metabolism of (R)-(+)-pulegone and (R)-(+)-menthofuran by human liver cytochrome P-450s: evidence for formation of a furan epoxide. Drug Metab Dispos 1999;27:574-580.

30. Wang EJ, Casciano CN, Clement RP, Johnson WW. Inhibition of P-glycoprotein transport function by grapefruit juice psoralen. Pharm Res 2001;18:432-438.

31. Wong WM, Wu PC, Yuen MF, Cheng CC, Yew WW, Lai CL, et al. Chronic hepatitis B carriers have more frequent and more severe liver injury with anti-tuberculosis drugs. Gastroenterology 1988;114:1366A.

32. Price VF, Miller MG, Jollow DJ. Mechanisms of fasting-induced potentiation of acetaminophen hepatotoxicity in the rat. Biochem Pharmacol 1987;36:427.

33. Lauterberg BH, Velez ME. Glutathione deficiency in alcoholic: risk factor for paracetamol hepatotoxicity. Gut 1988;29:1153.

Table 1
jkma-48-448-i001-l.jpg
Table 2
jkma-48-448-i002-l.jpg

SD: Standard Deviation, ALP: alkaline phosphatase, TB: total bilirubin

Table 3
jkma-48-448-i003-l.jpg
Table 4
jkma-48-448-i004-l.jpg
TOOLS
Share :
Facebook Twitter Linked In Google+ Line it
METRICS Graph View
  • 0 Crossref
  •   Scopus
  • 1,105 View
  • 2 Download
Related articles in
J Korean Med Assoc

Medicinal Herbs and Toxic Hepatitis2005 April;48(4)



ABOUT
ARTICLE CATEGORY

Browse all articles >

ARCHIVES
FOR CONTRIBUTORS
Editorial Office
37 Ichon-ro 46-gil, Yongsan-gu, Seoul
Tel: +82-2-6350-6562    Fax: +82-2-792-5208    E-mail: jkmamaster@gmail.com                

Copyright © 2024 by Korean Medical Association.

Developed in M2PI

Close layer
prev next